Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
Clinical trial NCT01081951 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01081951
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-04
- Primary completion
- 2011-10-10
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.